References
- Cooney D O. Historical background of activated charcoal. Activated Charcoal in Medical Applications. Marcel Dekker, Inc., New York 1995; 9–13
- Hort W P. Case of poisoning with corrosive sublimate, in which the administration of charcoal afforded great relief. Am J Med Sci 1834; 6: 540–541
- Garrod A B. On the influence of liquor potass and other alkalies on the therapeutic properties of henbane, belladonna and stramonium. Med Times Gaz 1857; 36(New Series 15)589–590
- Greensher J, Mofenson H C, Caraccio T R. Ascendency of the black bottle (activated charcoal). Pediatrics 1987; 80(6)949–950, [PUBMED], [INFOTRIEVE]
- Anderson H. Experimental studies on the pharmacology of activated charcoal. Acta Pharm 1948; 4: 275–284
- Cooney D O. Adsorption of phenobarbital, chlorpheniramine maleate, and theophylline by four commercially available activated charcoal suspensions. Clin Toxicol 1995; 33(3)213–217
- Roberts J R, Gracely E J, Schoffstall M D. Advantage of high‐surface‐area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model. Acad Emerg Med 1997; 4: 167–174, [PUBMED], [INFOTRIEVE]
- Tenenbein M, Cohen S, Sitar D S. Efficacy of ipecac‐induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med 1987; 16(8)838–841, [PUBMED], [INFOTRIEVE]
- Holt L E, Holz P H. The black bottle. Pediatrics 1963; 63(2)306–314
- Levy G. Gastrointestinal clearance of drugs with activated charcoal. NEJM 1982; 307(11)676–678, [PUBMED], [INFOTRIEVE]
- Kulig K. Initial management of ingestions of toxic substances. NEJM 1992; 326(25)1677–1681, [PUBMED], [INFOTRIEVE]
- Kulig K, Bar‐Or D, Cantrill S, Rosen P, Rumack B. Management of acutely poisoned patients without gastric emptying. Am J Emerg Med 1985; 14: 562–567
- Merigian K, Woodard M, Hedges J, Roberts J, Stuebing R, Rashkin M. Prospective evaluation of gastric emptying in the self‐poisoned patient. Am J Emerg Med 1990; 8: 479–483, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pond S, Lewis‐Driver D J, Williams G, Green A, Stevenson N. Gastric emptying in acute overdose: a prospective randomized controlled trial. Med J Aust 1995; 163: 345–349, [PUBMED], [INFOTRIEVE]
- Merigian K S, Blaho K E. Single‐dose activated charcoal in the treatment of self‐poisoned patient: a prospective. Randomized controlled trial. Am J Ther 2002; 9: 301–308, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Elliott C G, Colby T V, Kelly T M, Hicks H G. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96(3)672–674, [PUBMED], [INFOTRIEVE]
- Aaron C K, Primack W A, Manno M A, Fairfield S. Cardiac arrest from aspirated magnesium citrate/charcoal slurry. Clin Toxicol 1997; 35: 505
- Geller R J, Ekins B R. Death complicating gastrointestinal decontamination—time to rethink “routine therapy”?. J Toxicol Clin Toxicol 1996; 34: 595
- , TESS data 1993; case 432
- , TESS data 1993; case 143
- , TESS data 2000; case 321
- , TESS data 2000; case 738
- , TESS data 2000; case 763
- , TESS data 2000; case 494
- , TESS data 2000; case 794
- Pollack M, Dunbar B, Holbrook P, Fields A. Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10(10)528–529, [PUBMED], [INFOTRIEVE]
- Dammann K Z, Wiley S H, Tominack R L. Aspiration pneumonia following activated charcoal—a case report. Vet Hum Toxicol 1988; 30(4)353
- Silberman H, Davis S M, Lee A. Activated charcoal aspiration. NCMJ 1990; 51(2)79–80, [PUBMED], [INFOTRIEVE]
- Justiniani F R, Hippalgaonkar R, Martinez L O. Charcoal‐containing empyema complicating treatment for overdose. Chest 1985; 87(3)404–405, [PUBMED], [INFOTRIEVE]
- Graff G R. Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109(5)959–961, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Golej J, Biogner H, Burda G, Hermon M, Trittenwein G. Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49: 315–318, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sabga E, Dick A, Lertzman M, Tenenbein M. Direct administration of charcoal into the lung and pleural cavity. Ann Emerg Med 1997; 30(5)695–697, [PUBMED], [INFOTRIEVE]
- Dorrington C L, Johnson D W, Brant R. The frequency of complications associated with the use of multiple‐dose activated charcoal. Ann Emerg Med 2003; 41(3)370–376, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Folkesson H G, Matthay M A, Hebert Ca, Boraddus V C. Acid aspiration‐induced lung injury in rabbits is mediated by interleukin‐8‐depended mechanisms. J Clin Invest 1995; 96: 107–116, [PUBMED], [INFOTRIEVE]
- Arnold T C, Willis B H, Xiao F. Aspiration of activated charcoal elicits an increase in lung microvascular permeability. J Toxicol Clin Toxicol 1999; 37(1)9–16, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cohen A B, Gold W M. Defense mechanisms of the lungs. Annu Rev Physiol 1975; 37: 325–350, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end‐expiratory pressure. Am Rev Respir Dis 1988; 137: 1159–1164, [PUBMED], [INFOTRIEVE]
- Mariani P J, Pook N. Gastrointestinal tract perforation with charcoal peritoneum complicating orogastric intubation and lavage. Ann Emerg Med 1993; 22(3)606–609, [PUBMED], [INFOTRIEVE]
- McKinney P, Phillips S, Gomez H F, Brent J. Corneal abrasions secondary to activated charcoal. Vet Hum Toxicol 1992; 34: 336
- Tomaszewski C. Activated charcoal—treatment or toxin?. Clin Toxicol 1999; 37(1)17–18, [CROSSREF]
- Thakore S, Murphy N. The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19: 63–65, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Crockett R, Krishek S J, Manoguerra A, Williams S R, Clark R F. Prehospital use of activated charcoal: a pilot study. J Emerg Med 1996; 14(3)335–338, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Spiller H A, Rodgers G C. Evaluation of administration of activated charcoal in the home. Pediatrics 2001; 108(6)e100, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Scharman E J, Cloonan H A, Durback‐Morris L F. Home administration of charcoal: can mothers administer a therapeutic dose?. J Emerg Med 2001; 21(4)357–361, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ward R M, American Academy of Pediatrics, Committee on Drugs. Acetaminophen toxicity in children. Pediatrics 2001; 108: 1022–1023
- Litovitz T L, Klein‐Schwartz W, Rodgers G C, Cobaugh D J, Youniss J, Omslaer J C, May M E, Woolf A D, Benson B E. 2001 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2002; 20: 391–452, [PUBMED], [INFOTRIEVE], [CROSSREF]
- American Academy of Clinical Toxicology, European Association of Poison Centers and Clinical Toxicologists. Position statements. J Toxicol Clin Toxicol 1997; 35: 699–762
- Henry J A, Hoffman J R. Continuing controversy on gut decontamination. Lancet 1998; 352: 420–421, [PUBMED], [INFOTRIEVE]
- Karim A, Ivatts S, Darga P, Jones A. How feasible is it to conform to the European guidelines on administration of activated charcoal within one hour of an overdose?. Emerg Med J 2001; 18: 390–392, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Liebelt E L, DeAngelis C D. Evolving trends and treatment advances in pediatric poisoning. JAMA 1999; 282(12)1113–1115, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Krenzelok E P, McGuigan M, Lheur P. Position Statement: ipecac syrup. J Toxicol Clin Toxicol 1997; 35(7)699–709, [PUBMED], [INFOTRIEVE]
- Chyka P A, Seger D. Position statement: single‐dose activated charcoal. J Toxicol Clin Toxicol 1997; 35: 721–741, [PUBMED], [INFOTRIEVE]
- Sharpe V A, Faden A I. Medical harm. Historical, Conceptual, and Ethical Dimensions of Iatrogenic Illness. Cambridge University Press, New York, NY 1998
- Pellegrino E D. The anatomy of clinical judgements. Clinical Judgement: A Critical Appraisal D, H T Engelhardt, S F Spicker, B Towers. D. Reidel Publishing Company, DordrechtHolland 1979; Vol. 6: 169–215